IFALD in Children: What's New? A Narrative Review

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2022 Aug 12

PMID 35958249

Authors

Fabiola Di Dato

Raffaele Iorio

Maria Immacolata Spagnuolo

Affiliations

Soon will be listed here.

Abstract

Intestinal failure-associated liver disease (IFALD) is a progressive liver disease complicating intestinal failure (IF). It is a preventable and reversible condition, but at the same time, a potential cause of liver cirrhosis and an indication to combined or non-combined liver and small bowel transplantation. The diagnostic criteria are not yet standardized, so that its prevalence varies widely in the literature. Pathophysiology seems to be multifactorial, related to different aspects of intestinal failure and not only to the long-term parenteral nutrition treatment. The survival rates of children with IF have increased, so that the main problems today are preventing complications and ensuring a good quality of life. IFALD is one of the most important factors that limit long-term survival of patients with IF. For this reason, more and more interest is developing around it and the number of published articles is increasing rapidly. The purpose of this narrative review was to focus on the main aspects of the etiology, pathophysiology, management, prevention, and treatment of IFALD, based on what has been published mainly in the last 10 years. Controversies and current research gaps will be highlighted with the aim to pave the way for new project and high-quality clinical trials.

Citing Articles

Depletion of phytosterols from intravenous lipid emulsions: to be or not to be.

Jagadisan B, Dhawan A Pediatr Res. 2025; .

PMID: 39900833 DOI: 10.1038/s41390-025-03877-6.

Dipeptidyl peptidase IV inhibitors reduce hepatic fibrosis and lipid accumulation in rat intestinal failure-associated liver disease models.

Sueyoshi R, Ishii J, Yamada S, Kawakami M, Tanabe K, Segawa O Pediatr Surg Int. 2024; 40(1):281.

PMID: 39470835 DOI: 10.1007/s00383-024-05863-1.

Acquired Zinc Deficiency in Preterm Infant Post-Surgery for Necrotizing Enterocolitis (NEC) on Prolonged Total Parenteral Nutrition (TPN).

Al Qurashi M, Mohammad H, Aga S, Mustafa A, Alallah J, Al Hindi M Pediatr Rep. 2024; 16(3):551-557.

PMID: 39051233 PMC: 11270164. DOI: 10.3390/pediatric16030046.

Investigation of parenteral nutrition-induced hepatotoxicity using human liver spheroid co-cultures.

Mihajlovic M, De Boever S, Tabernilla A, Callewaert E, Sanz-Serrano J, Verhoeven A Arch Toxicol. 2024; 98(9):3109-3126.

PMID: 38740588 PMC: 11324701. DOI: 10.1007/s00204-024-03773-8.

Inflammation drives pathogenesis of early intestinal failure-associated liver disease.

Fligor S, Tsikis S, Hirsch T, Jain A, Sun L, Rockowitz S Sci Rep. 2024; 14(1):4240.

PMID: 38378873 PMC: 10879484. DOI: 10.1038/s41598-024-54675-9.

References

Mercer D, Hobson B, Fischer R, Talmon G, Perry D, Gerhardt B . Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion. J Pediatr Gastroenterol Nutr. 2012; 56(4):364-9. DOI: 10.1097/MPG.0b013e31827e208c. View

Ghirardello S, Raffaeli G, Scalambrino E, Cortesi V, Roggero P, Peyvandi F . Thrombin Generation in Preterm Newborns With Intestinal Failure-Associated Liver Disease. Front Pediatr. 2020; 8:510. PMC: 7479833. DOI: 10.3389/fped.2020.00510. View

Meyerson C, Naini B . Something old, something new: liver injury associated with total parenteral nutrition therapy and immune checkpoint inhibitors. Hum Pathol. 2019; 96:39-47. DOI: 10.1016/j.humpath.2019.10.007. View

Raphael B, Mitchell P, Gura K, Potemkin A, Squires R, Puder M . Growth in Infants and Children With Intestinal Failure-associated Liver Disease Treated With Intravenous Fish Oil. J Pediatr Gastroenterol Nutr. 2020; 70(2):261-268. DOI: 10.1097/MPG.0000000000002551. View

Dao D, Anez-Bustillos L, Finkelstein A, Mitchell P, OLoughlin A, Fell G . Trends of INR and Fecal Excretion of Vitamin K During Cholestasis Reversal: Implications in the Treatment of Neonates With Intestinal Failure-Associated Liver Disease. JPEN J Parenter Enteral Nutr. 2019; 44(5):951-958. PMC: 6944781. DOI: 10.1002/jpen.1677. View

Lauriti G, Zani A, Aufieri R, Cananzi M, Lelli Chiesa P, Eaton S . Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review. JPEN J Parenter Enteral Nutr. 2013; 38(1):70-85. DOI: 10.1177/0148607113496280. View

Kapoor V, Malviya M, Soll R . Lipid emulsions for parenterally fed term and late preterm infants. Cochrane Database Syst Rev. 2019; 6:CD013171. PMC: 6953354. DOI: 10.1002/14651858.CD013171.pub2. View

Mutanen A, Lohi J, Merras-Salmio L, Koivusalo A, Pakarinen M . Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure. J Hepatol. 2020; 74(3):593-602. DOI: 10.1016/j.jhep.2020.09.023. View

Lim D, Wales P, Josephson J, Nation P, Wizzard P, Sergi C . Glucagon-Like Peptide 2 Improves Cholestasis in Parenteral Nutrition--Associated Liver Disease. JPEN J Parenter Enteral Nutr. 2014; 40(1):14-21. DOI: 10.1177/0148607114551968. View

10.

Norsa L, Artru S, Lambe C, Talbotec C, Pigneur B, Ruemmele F . Long term outcomes of intestinal rehabilitation in children with neonatal very short bowel syndrome: Parenteral nutrition or intestinal transplantation. Clin Nutr. 2018; 38(2):926-933. DOI: 10.1016/j.clnu.2018.02.004. View

11.

Lawrence A, Dienhart M, Cooper J, Lodwick D, Lopez J, Fung B . Ultrasound Elastography as a Non-Invasive Method to Monitor Liver Disease in Children with Short Bowel Syndrome: Updated Results. J Pediatr Surg. 2019; 54(6):1179-1183. DOI: 10.1016/j.jpedsurg.2019.02.039. View

12.

Calkins K, Debarber A, Steiner R, Flores M, Grogan T, Henning S . Intravenous Fish Oil and Pediatric Intestinal Failure-Associated Liver Disease: Changes in Plasma Phytosterols, Cytokines, and Bile Acids and Erythrocyte Fatty Acids. JPEN J Parenter Enteral Nutr. 2017; 42(3):633-641. PMC: 5665720. DOI: 10.1177/0148607117709196. View

13.

Capriati T, Mosca A, Alterio T, Spagnuolo M, Gandullia P, Lezo A . To Wean or Not to Wean: The Role of Autologous Reconstructive Surgery in the Natural History of Pediatric Short Bowel Syndrome on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP). Nutrients. 2020; 12(7). PMC: 7400841. DOI: 10.3390/nu12072136. View

14.

Hojsak I, Colomb V, Braegger C, Bronsky J, Campoy C, Domellof M . ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis. J Pediatr Gastroenterol Nutr. 2016; 62(5):776-92. DOI: 10.1097/MPG.0000000000001121. View

15.

Wang J, Yan W, Lu L, Tao Y, Huang L, Cai W . Intestinal Continuity Alleviates Pediatric Intestinal Failure-Associated Liver Disease. Front Surg. 2022; 9:881782. PMC: 9149254. DOI: 10.3389/fsurg.2022.881782. View

16.

Ganousse-Mazeron S, Lacaille F, Colomb-Jung V, Talbotec C, Ruemmele F, Sauvat F . Assessment and outcome of children with intestinal failure referred for intestinal transplantation. Clin Nutr. 2014; 34(3):428-35. DOI: 10.1016/j.clnu.2014.04.015. View

17.

Migliarese Isaac D, Alzaben A, Mazurak V, Yap J, Wizzard P, Nation P . Mixed Lipid, Fish Oil, and Soybean Oil Parenteral Lipids Impact Cholestasis, Hepatic Phytosterol, and Lipid Composition. J Pediatr Gastroenterol Nutr. 2019; 68(6):861-867. DOI: 10.1097/MPG.0000000000002313. View

18.

Colomb V, Lacaille F, Goulet O, Fournet J, Ricour C . Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000; 24(6):345-50. DOI: 10.1177/0148607100024006345. View

19.

Diamond I, Grant R, Pencharz P, de Silva N, Feldman B, Fitzgerald P . Preventing the Progression of Intestinal Failure-Associated Liver Disease in Infants Using a Composite Lipid Emulsion: A Pilot Randomized Controlled Trial of SMOFlipid. JPEN J Parenter Enteral Nutr. 2016; 41(5):866-877. DOI: 10.1177/0148607115626921. View

20.

Mutanen A, Lohi J, Heikkila P, Jalanko H, Pakarinen M . Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure. J Hepatol. 2015; 62(6):1391-7. DOI: 10.1016/j.jhep.2015.01.004. View